{"cdcTestId":"2022-0058","testcaseName":"Patient is 8 years of age and has been administered the Pfizer Covid-19 vaccine as first and second dose and Janssen Covid-19 vaccine as a booster dose ","vaccineGroup":"COVID-19","evaluationTestType":"Vaccine: Invalid Usage","forecastTestType":"Recommended based on minimum interval from invalid dose","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2014-08-24T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Janssen (J\u0026J) COVID-19 Vaccine","cvx":"212","mvx":"JSN","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"}]},"forecast":{"forecastNum":"3","earliestDate":"2022-12-14T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Janssen (J\u0026J) COVID-19 Vaccine","cvx":"212","mvx":"JSN","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"}],"dateAdded":"2022-05-16T20:00:00","dateUpdated":"2022-10-19T12:21:18.865","generalDescription":"This test case describes when a patient that is 8 years of age has been administered Janssen Covid19 vaccine as a third dose, that the dose is not valid.  Another dose should be forecast.","changedInVersion":"4.28","reasonForChange":"v4.28 Updated the test cased based on new updated Interim Clinical Considerations for a new COVID-19 booster recommendation for people ages 5 years and older to receive 1 bivalent MRNA booster dose, at least 2 months, after completion of a monovalent primary series; these recommendations replace all booster recommendations for this age group."}